Matches in SemOpenAlex for { <https://semopenalex.org/work/W2740723077> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2740723077 endingPage "1567" @default.
- W2740723077 startingPage "1562" @default.
- W2740723077 abstract "For patients with nonvalvular atrial fibrillation (NVAF) receiving warfarin therapy, the target international normalized ratio range of 2.0 to 3.0 is recommended by Western countries. However, this treatment carries a higher risk of bleeding which suggests more researches on whether low-intensity warfarin therapy (range <2.0 to 3.0) is suitable for East Asian patients. Three databases were searched from inception to April 21, 2016. Studies that reported thromboembolic and hemorrhagic events in low- and standard-intensity warfarin groups were included. Finally, seven studies were included in the analysis. There was a significantly decreased risk of hemorrhagic events (odds ratio [OR] 0.59, 95% confidence interval [CI] 0.43 to 0.82, p = 0.002) with no statistically increased risk of thromboembolic events (OR 1.14, 95% CI 0.80 to 1.62, p = 0.47) in the 1.5 to 2.0 group compared with that of the 2.0 to 3.0 group. Meanwhile, there was no significant difference of cardiovascular mortality (OR 1.58, 95% CI 0.89 to 2.83, p = 0.12) between the 2 groups. Further analysis showed there was no significance in thromboembolic events (OR 1.15, 95% CI 0.83 to 1.60, p = 0.40), major bleeding events (OR 0.74, 95% CI 0.50 to 1.09, p = 0.13), and cardiovascular mortality (OR 1.45, 95% CI 0.79 to 2.65, p = 0.23) between 1.5 to 2.5 and 2.0 to 3.0 groups. Although no significant difference was found in hemorrhagic events (OR 0.76, 95% CI 0.57 to 1.01, p = 0.06), there was a decreased trend in it. In conclusion, low-intensity warfarin therapy can achieve reduced hemorrhage without increasing thromboembolism for East Asian patients with NVAF receiving warfarin therapy." @default.
- W2740723077 created "2017-08-08" @default.
- W2740723077 creator A5006727238 @default.
- W2740723077 creator A5022804352 @default.
- W2740723077 creator A5063089557 @default.
- W2740723077 creator A5074900624 @default.
- W2740723077 creator A5077363239 @default.
- W2740723077 creator A5080785284 @default.
- W2740723077 creator A5091526740 @default.
- W2740723077 date "2017-11-01" @default.
- W2740723077 modified "2023-10-05" @default.
- W2740723077 title "Meta-Analysis of Efficacy and Safety of Low-Intensity Warfarin Therapy for East Asian Patients With Nonvalvular Atrial Fibrillation" @default.
- W2740723077 cites W1977016143 @default.
- W2740723077 cites W1986506316 @default.
- W2740723077 cites W1989170054 @default.
- W2740723077 cites W2015696505 @default.
- W2740723077 cites W2027137858 @default.
- W2740723077 cites W2029158645 @default.
- W2740723077 cites W2043024590 @default.
- W2740723077 cites W2081205482 @default.
- W2740723077 cites W2082168979 @default.
- W2740723077 cites W2110167268 @default.
- W2740723077 cites W2125435699 @default.
- W2740723077 cites W2152115221 @default.
- W2740723077 cites W2166503147 @default.
- W2740723077 cites W2321584584 @default.
- W2740723077 cites W2511867665 @default.
- W2740723077 cites W653423292 @default.
- W2740723077 doi "https://doi.org/10.1016/j.amjcard.2017.07.050" @default.
- W2740723077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28847595" @default.
- W2740723077 hasPublicationYear "2017" @default.
- W2740723077 type Work @default.
- W2740723077 sameAs 2740723077 @default.
- W2740723077 citedByCount "20" @default.
- W2740723077 countsByYear W27407230772018 @default.
- W2740723077 countsByYear W27407230772019 @default.
- W2740723077 countsByYear W27407230772020 @default.
- W2740723077 countsByYear W27407230772021 @default.
- W2740723077 countsByYear W27407230772022 @default.
- W2740723077 countsByYear W27407230772023 @default.
- W2740723077 crossrefType "journal-article" @default.
- W2740723077 hasAuthorship W2740723077A5006727238 @default.
- W2740723077 hasAuthorship W2740723077A5022804352 @default.
- W2740723077 hasAuthorship W2740723077A5063089557 @default.
- W2740723077 hasAuthorship W2740723077A5074900624 @default.
- W2740723077 hasAuthorship W2740723077A5077363239 @default.
- W2740723077 hasAuthorship W2740723077A5080785284 @default.
- W2740723077 hasAuthorship W2740723077A5091526740 @default.
- W2740723077 hasConcept C126322002 @default.
- W2740723077 hasConcept C156957248 @default.
- W2740723077 hasConcept C164705383 @default.
- W2740723077 hasConcept C2776301958 @default.
- W2740723077 hasConcept C2779161974 @default.
- W2740723077 hasConcept C44249647 @default.
- W2740723077 hasConcept C71924100 @default.
- W2740723077 hasConceptScore W2740723077C126322002 @default.
- W2740723077 hasConceptScore W2740723077C156957248 @default.
- W2740723077 hasConceptScore W2740723077C164705383 @default.
- W2740723077 hasConceptScore W2740723077C2776301958 @default.
- W2740723077 hasConceptScore W2740723077C2779161974 @default.
- W2740723077 hasConceptScore W2740723077C44249647 @default.
- W2740723077 hasConceptScore W2740723077C71924100 @default.
- W2740723077 hasIssue "9" @default.
- W2740723077 hasLocation W27407230771 @default.
- W2740723077 hasLocation W27407230772 @default.
- W2740723077 hasOpenAccess W2740723077 @default.
- W2740723077 hasPrimaryLocation W27407230771 @default.
- W2740723077 hasRelatedWork W131995492 @default.
- W2740723077 hasRelatedWork W1967841144 @default.
- W2740723077 hasRelatedWork W2000789055 @default.
- W2740723077 hasRelatedWork W2018480046 @default.
- W2740723077 hasRelatedWork W2057095293 @default.
- W2740723077 hasRelatedWork W2263197009 @default.
- W2740723077 hasRelatedWork W2319489406 @default.
- W2740723077 hasRelatedWork W2340635798 @default.
- W2740723077 hasRelatedWork W2763816051 @default.
- W2740723077 hasRelatedWork W2945399567 @default.
- W2740723077 hasVolume "120" @default.
- W2740723077 isParatext "false" @default.
- W2740723077 isRetracted "false" @default.
- W2740723077 magId "2740723077" @default.
- W2740723077 workType "article" @default.